Plain-English translation of NCT06249412 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a breathing assistance device called an in-exsufflator, which helps people with ALS cough by applying gentle pressure changes through a mask. The trial is specifically looking at whether adding positive expiratory pressure (a gentle outward pressure during the pause phase) makes the treatment work better at clearing airway secretions and reducing pneumonia risk.
ALS gradually weakens the muscles used for coughing, making it harder for people to clear mucus and secretions from their lungs. This can lead to serious lung infections. While breathing assistance devices help, they don't work well for everyone, especially those with certain types of ALS affecting swallowing and speech. This trial is testing whether adding a specific pressure adjustment could help more patients benefit from this life-saving therapy.
You likely qualify if…
You likely don't qualify if…
You will receive breathing assistance sessions using the in-exsufflator device, typically lasting 8 to 15 minutes depending on how you tolerate it. During the study, you'll try the device with and without the positive pressure setting, with a 30-minute break between sessions. A trained respiratory therapist will adjust the pressure settings to find what works best for you, measuring how well you're able to cough and clear your airway.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
France